Regeneron Pharmaceuticals (REGN) Receivables - Other (2009 - 2020)
Regeneron Pharmaceuticals (REGN) posted quarterly Receivables - Other of $460.8 million for Q3 2020, up 33.41% year-over-year from $345.4 million in Q4 2019, and up 18.4% quarter-over-quarter from $389.2 million in Q2 2020.
Regeneron Pharmaceuticals (REGN) Receivables - Other (2009 - 2020) Analysis & Trends
Regeneron Pharmaceuticals' Receivables - Other history runs 12 years deep, the most recent figure standing at $460.8 million for Q3 2020.
- In Q3 2020, Receivables - Other rose 33.41% year-over-year to $460.8 million; the TTM figure through Sep 2020 stood at $460.8 million (up 33.41% YoY), while the FY2019 annual figure was $260.6 million, up 15.11% from the prior year.
- Receivables - Other for Q3 2020 stood at $460.8 million, up from $389.2 million in the prior quarter.
- The five-year high for Receivables - Other was $468.3 million in Q1 2020, with the low at $93.0 million in Q4 2016.
- The 5-year median for Receivables - Other is $226.4 million (2018), against an average of $249.8 million.
- The sharpest annual moves came in 2016 and 2017: Receivables - Other plunged 39.28% in 2016, then jumped 108.3% in 2017.
- Regeneron Pharmaceuticals' Receivables - Other stood at $93.0 million in 2016, then surged by 108.3% to $193.7 million in 2017, then advanced by 16.88% to $226.4 million in 2018, then advanced by 15.11% to $260.6 million in 2019, then jumped by 76.82% to $460.8 million in 2020.
- Business Quant data shows REGN's Receivables - Other at $460.8 million in Q3 2020, $389.2 million in Q2 2020, and $468.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 460.80 Mn |
| Sep 30, 2020 | 460.80 Mn |
| Jun 30, 2020 | 389.20 Mn |
| Jun 30, 2020 | 389.20 Mn |
| Mar 31, 2020 | 468.30 Mn |
| Mar 31, 2020 | 468.30 Mn |
| Dec 31, 2019 | 260.60 Mn |
| Dec 31, 2019 | 260.60 Mn |
| Sep 30, 2019 | 345.40 Mn |
| Sep 30, 2019 | 345.40 Mn |
| Jun 30, 2019 | 252.00 Mn |
| Jun 30, 2019 | 252.00 Mn |
| Mar 31, 2019 | 287.60 Mn |
| Mar 31, 2019 | 287.60 Mn |
| Dec 31, 2018 | 226.40 Mn |
| Dec 31, 2018 | 226.40 Mn |
| Sep 30, 2018 | 269.27 Mn |
| Sep 30, 2018 | 269.27 Mn |
| Jun 30, 2018 | 243.24 Mn |
| Jun 30, 2018 | 243.24 Mn |